首页> 外文期刊>Case Reports in Ophthalmology >One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
【24h】

One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy

机译:一名接受兰尼单抗难治性多发性脉络膜脉络膜血管病的白人患者的Abribercept和光动力疗法的一年结果

获取原文
           

摘要

Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration characterised by an abnormal branching vascular network with aneurysmal polypoidal choroidal vascular lesions. PCV is more prevalent in Asian populations
机译:息肉样脉络膜血管病(PCV)是新血管性年龄相关性黄斑变性的一种亚型,其特征是动脉分支性息肉样脉络膜脉络膜血管病变的分支血管网络异常。 PCV在亚洲人群中更为普遍

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号